Nature Research Round Table: Pluripotency Tests
Dr. Peter Andrews discusses what the term “pluripotency” means in relation to ES and iPS cells, how the term has evolved, and how to assess pluripotent potential by comparing existing assays. Dr. Andrews is co-director of the Centre for Stem Cell Biology at the University of Sheffield. This presentation and the following Q&A session were moderated by Dr. Ludovic Vallier from the Wellcome Trust Sanger Institute.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
Publish Date:
November 01, 2019
Views: 0
Related Multimedia
-
Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Banking - Panel Discussion
Publish Date: November 01, 2019 -
Nature Research Round Table: Maintenance of Human Pluripotent Stem Cells In Vitro
Publish Date: November 01, 2019 -
Nature Research Round Table: Regulations Around Human Induced Pluripotent Stem Cell Registration
Publish Date: November 01, 2019
Explore Our Products
-
STEMdiff™ Trilineage Differentiation Kit
Functional assay kit to assess pluripotency by directed differentiation of human ES and iPS cells to all three germ layers -
Human Pluripotent Stem Cell Trilineage Differentiation qPCR Array
For characterization of hPSC trilineage differentiation to endoderm, mesoderm, and ectoderm germ layers -
qPCR analysis kit for detecting the majority of karyotypic abnormalities reported in human ES and iPS cells -
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells
